Mohammed A. Elbahloul: Every Minute Counts in STEMI Revascularization
Mohammed A. Elbahloul, Guest Editor at Plos One, shared a post on LinkedIn about a recent article he and her colleagues co-authored, published in Cardiovascular Interventions logo Journal, adding:
”I’m pleased to share that our manuscript, ‘Timing of Complete Revascularization in Patients With STEMI and Multivessel Disease: An Updated Meta-Analysis of Randomized Clinical Trials,’ has been published in Circulation: Cardiovascular Interventions (IF: 7.4).
I would like to express my sincere gratitude to my co-authors and mentors for their invaluable contributions and support throughout this work.
Key Findings:
- Primary Outcome: In hemodynamically stable patients with STEMI and multivessel disease, an immediate complete revascularization (ICR) strategy may be associated with an increased risk of short-term cardiac death compared with staged complete revascularization (SCR).
- Mortality Trends: Based on the current evidence, a potential increase in both early and late all-cause mortality with ICR cannot be excluded.
- Secondary Endpoints: No significant differences were observed between ICR and SCR in myocardial infarction, repeat revascularization, stent thrombosis, stroke, or major bleeding.
- Clinical Implications: While some uncertainty remains, these findings support a staged complete revascularization strategy for most patients with STEMI and multivessel disease.”
Title: Timing of Complete Revascularization in Patients With STEMI and Multivessel Disease: An Updated Meta-Analysis of Randomized Clinical Trials
Authors: Mohammed A. Elbahloul, Shrouk Ramadan, Eman E. Labeeb, Shahed Aldalahmeh, Ahella Ismail A. Mousa, Ahmed Elazab, Ahmed N. Mohamed, Ahmad Elashery, Mehiar O. El-Hamdani, Carl J. Lavie, Gregg W. Stone
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention